SEC Info - Soros Fund Management LLC, et al. - ‘4’ for 8/5/05 re: Auxilium Pharmaceuticals Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SOROS FUND MANAGEMENT LLC

(Last)

(First)

(Middle)

888 SEVENTH AVENUE

33RD FLOOR

(Street)

NEW YORK

10106

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AUXILIUM PHARMACEUTICALS INC [ AUXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
8/5/05

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (Right to Buy)	$4.15	8/5/05		J ⁽²⁾			10,000	6/8/06 ⁽¹⁾	6/8/15	Common Stock	10,000	⁽²⁾	10,000	I	See footnote ⁽²⁾

1. Name and Address of Reporting Person^*

SOROS FUND MANAGEMENT LLC

(Last)

(First)

(Middle)

888 SEVENTH AVENUE

33RD FLOOR

(Street)

NEW YORK

10106

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

SOROS GEORGE

(Last)

(First)

(Middle)

888 SEVENTH AVE

33RD FLR

(Street)

NEW YORK

10106

(City)

(State)

(Zip)

Explanation of Responses:

(1) This option vests 100% on June 8, 2006 (one year after Mr. Dennis J. Purcell ("Mr. Purcell") was re-elected to serve as a director of the Issuer).

(2) Represents nonqualified stock options to purchase 10,000 shares of common stock issued to Mr. Purcell. These options are held for the benefit of an entity of which Soros Fund Management LLC, a Delaware limited liability company ("SFM LLC"), may be deemed to be affiliated. Mr. George Soros ("Mr. Soros") serves as Chariman of SFM LLC.

Remarks:

Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), SFM LLC and Mr. Soros may be deemed to be the beneficial owners of the securities reported herein only to the extent of his or its pecuniary interest therein. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that SFM LLC or Mr. Soros are, for purposes of Section 16 of the Act or otherwise, the beneficial owners of any securities reported herein in excess of such amount.

	/s/ Jay Schoenfarber, Assistant General Counsel of Soros Fund Management LLC	8/9/05
	/s/ Jay Schoenfarber, Attorney-in-Fact for Mr. George Soros	8/9/05
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Code:
J	Other acquisition or disposition.

Soros Fund Management LLC, et al. – ‘4’ for 8/5/05 re: Auxilium Pharmaceuticals Inc.

On: Tuesday, 8/9/05, at 6:51pm ET · For: 8/5/05 · As: 10% Owner · Accession #: 950142-5-2240 · File #: 0-50855

Previous ‘4’: ‘4’ on 7/28/05 for 7/26/05 · Next: ‘4’ on 12/15/05 for 12/14/05 · Latest: ‘4’ on 8/16/18 for 8/14/18

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Soros Fund Management LLC, et al. – ‘4’ for 8/5/05 re: Auxilium Pharmaceuticals Inc.

On: Tuesday, 8/9/05, at 6:51pm ET · For: 8/5/05 · As: 10% Owner · Accession #: 950142-5-2240 · File #: 0-50855

Previous ‘4’: ‘4’ on 7/28/05 for 7/26/05 · Next: ‘4’ on 12/15/05 for 12/14/05 · Latest: ‘4’ on 8/16/18 for 8/14/18

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents